NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
about
Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discoverySintered indium-tin oxide particles induce pro-inflammatory responses in vitro, in part through inflammasome activationRole of Nrf2 in oxidative stress and toxicityTowards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesLiver x receptors in atherosclerosis and inflammationThe inflammasome: in memory of Dr. Jurg TschoppRegulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responsesEctopic mineralization in the middle ear and chronic otitis media with effusion caused by RPL38 deficiency in the Tail-short (Ts) mouse.Extracellular Release and Signaling by Heat Shock Protein 27: Role in Modifying Vascular InflammationQuestions and controversies in innate immune research: what is the physiological role of NLRP3?Monocyte Activation in Immunopathology: Cellular Test for Development of Diagnostics and TherapyModulation of inflammasome activity by Porphyromonas gingivalis in periodontitis and associated systemic diseasesSmall Heterodimer Partner and Innate Immune RegulationFrom C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for AtheroprotectionSecondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damageMolecular mechanisms regulating NLRP3 inflammasome activationLeukotriene B4 as a Potential Therapeutic Target for the Treatment of Metabolic DisordersMacrophage-mediated cholesterol handling in atherosclerosisMacrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on AtherosclerosisRoles of Commensal Microbiota in Pancreas Homeostasis and Pancreatic PathologiesTRPM2 Channel-Mediated ROS-Sensitive Ca(2+) Signaling Mechanisms in Immune CellsTreating rheumatological diseases and co-morbidities with interleukin-1 blocking therapiesNLRP3 Inflammasome and Pathobiology in AMDMicroglial cell dysregulation in brain aging and neurodegenerationAntioxidants, inflammation and cardiovascular diseaseReactive oxygen species at the crossroads of inflammasome and inflammationUric acid, hyperuricemia and vascular diseasesEndothelial dysfunction: the role of sterol regulatory element-binding protein-induced NOD-like receptor family pyrin domain-containing protein 3 inflammasome in atherosclerosisAnti-inflammatory therapy in chronic disease: challenges and opportunitiesInvestigating the role of nucleotide-binding oligomerization domain-like receptors in bacterial lung infectionGraft rejection - endogenous or allogeneic?The influence of innate and adaptive immune responses on atherosclerosisOf inflammasomes and pathogens--sensing of microbes by the inflammasomeThe role of T and B cells in human atherosclerosis and atherothrombosisThe immune system's involvement in obesity-driven type 2 diabetesInflammasomes: mechanism of action, role in disease, and therapeuticsThe NLRP3 inflammasome and strokeAdipose tissue as an immunological organAn Update on PYRIN Domain-Containing Pattern Recognition Receptors: From Immunity to PathologyA clear and present danger: inflammasomes DAMPing down disorders of pregnancy
P2860
Q21285000-34F4C819-6B65-471F-9E0E-41DB161035B6Q23918175-57968CD4-569B-4695-A992-E65A318D4C12Q23919669-5306FF31-2865-4B51-B642-B65C31B1D1DFQ24289511-00C41D0D-AB81-46DE-927B-7B9E6922BCEBQ24608256-AC298B1D-006F-4A0F-81CD-06E4FDD9E306Q24613816-FB223137-1F73-4A38-AE4D-08A7CF92C241Q24631052-6E05892F-4D94-4331-9CC3-FC4DCC7AEEE5Q24634244-B73439F5-98B1-4DC7-B5A0-77E6D74A17CEQ26738276-79E279B6-061D-4D63-97F0-11ECC4ED1CCBQ26739753-8C7036C7-A027-45BF-8CE9-76AFDCD7DB16Q26765189-61BE8153-689C-44E5-89AD-2F7D38FE5F1FQ26768562-F2AC1735-A667-42EE-80F9-B5AE4834735BQ26769682-3D009BE5-A15B-4185-97BF-84376B0A4A89Q26770209-378A3D1E-001E-451D-A11C-F00DCFCEC11FQ26770744-DCF361A5-5DBA-4E04-AD3D-ADE6162A7C97Q26778556-E9B794A8-BC6C-496C-9DC4-3D369A05398AQ26779189-B9B822FE-5147-4B0C-A12F-C8A8EF6584EAQ26780405-B798B6ED-1798-498F-8222-8EE899A1CA60Q26780531-A1A8B71E-5C8F-4709-AF34-7D13ADE01A32Q26782979-BD00CAB3-CEDF-44F8-9FBD-B04854842A4FQ26795462-3E02FC53-9C73-4194-902A-E71454233BECQ26799747-CDA81B90-EAD3-4420-979C-78329FC28964Q26799766-A8B2C041-5E86-4E28-AD1B-20058675E9DBQ26800212-6F17105A-2B96-472A-A140-6416F40541D5Q26823009-DB12FBA4-15EE-4387-9B28-CE1EDB29324FQ26830685-AD4EAE35-AB18-4CD1-93F6-FC4500B9290BQ26850727-4E4E68F9-BA5A-493D-A18B-818E950918CCQ26852572-E7DCB0BB-968A-477E-8AED-2D6A993C8CACQ26860162-5DF0F54E-F5E6-49C5-ACD3-BDA4C052DEA7Q26863593-ADD159E6-19F5-4D25-A5E5-E97614864692Q26866523-F1587A52-9C39-4CBB-9CF5-83E39E9C2A28Q27000370-4F24F2F4-28F8-422C-8580-AC8AA096CAFBQ27000785-E7295F25-D65C-4CCB-B7A7-7D919990CB3EQ27000791-D8693C7A-076D-4A5B-A3A9-69013475DB0FQ27001164-5B905C92-49A8-48E2-8883-D5CB691717A7Q27001186-FBB406B3-1657-47F7-A833-6EC45902F769Q27001659-E06F5736-5000-488A-B442-04F9FC160A47Q27003461-A3A41C41-5E49-4D98-9EB9-E2250AB49C82Q27004333-4CC667AA-7633-4BA5-8CE5-35A0E8FA5417Q27007734-AB67DAD6-0239-40CA-B3A6-85D970D96282
P2860
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
@ast
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
@en
type
label
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
@ast
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
@en
prefLabel
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
@ast
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
@en
P2093
P2860
P50
P3181
P356
P1433
P1476
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
@en
P2093
Eicke Latz
Franz G Bauernfeind
Gabriel Nuñez
George S Abela
Gregory Vladimer
Katherine A Fitzgerald
Kenneth L Rock
Luigi Franchi
Max Schnurr
Samuel D Wright
P2507
P2860
P2888
P304
P3181
P356
10.1038/NATURE08938
P407
P50
P577
2010-04-01T00:00:00Z
P6179
1025625953